<bill session="117" type="s" number="3357" updated="2022-12-30T03:34:02Z">
  <state datetime="2021-12-09">REFERRED</state>
  <status>
    <introduced datetime="2021-12-09"/>
  </status>
  <introduced datetime="2021-12-09"/>
  <titles>
    <title type="display">Humane Cosmetics Act of 2021</title>
    <title type="official" as="introduced">A bill to substantially restrict the use of animal testing for cosmetics.</title>
    <title type="short" as="introduced">Humane Cosmetics Act of 2021</title>
  </titles>
  <sponsor bioguide_id="B001288"/>
  <cosponsors>
    <cosponsor bioguide_id="B001277" joined="2022-09-28"/>
    <cosponsor bioguide_id="C000127" joined="2022-06-07"/>
    <cosponsor bioguide_id="C001035" joined="2021-12-09"/>
    <cosponsor bioguide_id="D000563" joined="2022-12-14"/>
    <cosponsor bioguide_id="H001076" joined="2022-06-07"/>
    <cosponsor bioguide_id="H000273" joined="2021-12-09"/>
    <cosponsor bioguide_id="K000383" joined="2022-06-07"/>
    <cosponsor bioguide_id="L000174" joined="2022-09-28"/>
    <cosponsor bioguide_id="P000145" joined="2022-11-15"/>
    <cosponsor bioguide_id="P000595" joined="2022-06-07"/>
    <cosponsor bioguide_id="P000449" joined="2021-12-09"/>
    <cosponsor bioguide_id="R000122" joined="2022-09-29"/>
    <cosponsor bioguide_id="R000608" joined="2021-12-09"/>
    <cosponsor bioguide_id="S000033" joined="2022-09-15"/>
    <cosponsor bioguide_id="S001194" joined="2022-11-15"/>
    <cosponsor bioguide_id="S001181" joined="2022-09-28"/>
    <cosponsor bioguide_id="W000805" joined="2022-06-09"/>
    <cosponsor bioguide_id="W000817" joined="2022-06-07"/>
    <cosponsor bioguide_id="W000802" joined="2022-06-07"/>
  </cosponsors>
  <actions>
    <action datetime="2021-12-09">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-12-09" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="6207" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Animal protection and human-animal relationships"/>
    <term name="Business records"/>
    <term name="Civil actions and liability"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Cosmetics and personal care"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Federal preemption"/>
    <term name="Government information and archives"/>
    <term name="Marketing and advertising"/>
    <term name="Product development and innovation"/>
    <term name="Product safety and quality"/>
    <term name="Research administration and funding"/>
    <term name="Retail and wholesale trades"/>
    <term name="State and local government operations"/>
  </subjects>
  <amendments/>
  <summary date="2022-01-04T22:56:38Z" status="Introduced in Senate">Humane Cosmetics Act of 2021

This bill generally prohibits animal testing in the evaluation of cosmetic products, and it prohibits the sale or transport of cosmetics developed using animal testing, subject to civil penalties. These prohibitions begin one year after enactment.

The bill specifies exceptions to these prohibitions, including if such animal testing (1) is conducted outside the United States to comply with a foreign regulatory authority; (2) is pursuant to a specified finding that there are no nonanimal alternatives to test the safety of a potentially dangerous cosmetic product or ingredient; (3) is of a product or ingredient for a drug or device subject to regulation by the Food and Drug Administration (FDA); or (4) is required for a noncosmetic purpose pursuant to a state, federal, or foreign regulatory authority.

Further, no animal-testing evidence may be used to establish the safety of a cosmetic product or ingredient that is regulated by the FDA after the effective date of this bill, subject to limited exceptions.</summary>
</bill>
